David M. Orenstein

The Prognostic Value of Exercise Testing in Patients with Cystic Fibrosis

Patricia A. Nixon, David M. Orenstein, Sheryl F. Kelsey et al. · New England Journal of Medicine · 1992 · 634 citations · Full text

Medicine, Physiology, Exercise Testing +15

The Quality of Well-Being Scale

Robert M. Kaplan, John P. Anderson, Albert W. Wu et al. · Medical Care · 1989 · 348 citations

Pharmacy, Health Behavior, Health Assessment +16

Efficacy and safety of lumacaftor and ivacaftor in patients aged 6–11 years with cystic fibrosis homozygous for F508del-CFTR : a randomised, placebo-controlled phase 3 trial

Félix Ratjen, Christopher Hug, Gautham Marigowda et al. · The Lancet Respiratory Medicine · 2017 · 295 citations

Medicine, Pediatrics, Pharmacotherapy +12

Exercise Conditioning and Cardiopulmonary Fitness in Cystic Fibrosis

David M. Orenstein, Barry A. Franklin, Carl F. Doershuk et al. · CHEST Journal · 1981 · 213 citations

Medicine, Physiology, Rehabilitation Medicine +15

Comparative Efficacy and Safety of 4 Randomized Regimens to Treat Early<i>Pseudomonas aeruginosa</i>Infection in Children With Cystic Fibrosis

Miriam M. Treggiari, George Retsch‐Bogart, Nicole Mayer-Hamblett et al. · Archives of Pediatrics and Adolescent Medicine · 2011 · 213 citations · Full text

Pharmacy, Infectious Diseases, Pediatrics +13